Finance

Lists
PEN:NYSE
Penumbra Inc
$324.22
+0.36%
(+1.16) 1D
$324.22
0.00% (0.00)
After hours
Closed: Aug 4, 4:00:04 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PEN...
Open
$321.57
High
$324.35
Low
$321.35
Mkt. cap
12.77B
Avg. vol.
387.05K
Volume
363.25K
P/E ratio
79.63
52-wk high
$362.41
52-wk low
$221.26
EPS
$4.07
Beta
0.71
Shares outstanding
39.39M
No. of employees
5K
Open
$321.57
High
$324.35
Low
$321.35
Mkt. cap
12.77B
Avg. vol.
387.05K
Volume
363.25K
P/E ratio
79.63
52-wk high
$362.41
52-wk low
$221.26
EPS
$4.07
Beta
0.71
Shares outstanding
39.39M
No. of employees
5K
News stories
From sources across the web
Profile
Penumbra, Inc. is an American medical device company headquartered in Alameda, California. The company was founded by Arani Bose and Adam Elsesser in 2004. It manufactures devices for interventional therapies to treat vascular conditions such as stroke and aneurysm. In January 2026, Boston Scientific announced it would acquire Penumbra in a $15 billion cash and stock deal. The deal was expected to close by year-end. Wikipedia
About Penumbra Inc
CEOAdam Elsesser
Employees4.7K
Founded2004
Headquarters-
SectorMedical device
Websitepenumbrainc.com
Analyst ratings
Based on 6 analysts giving stock ratings to PEN in the past 3 months
Hold
Buy
1
Hold
5
Sell
0
12-month forecast
Based on 6 Wall Street analysts offering 12 month price targets for PEN in the last 3 months.
Highest
Current $324.22
$374.00 (+15.35%)
Average
$358.40 (+10.54%)
Lowest
$320.00 (-1.30%)
Analyst
Recommendation
Action
Price target
Projected
Date
William Plovanic
Canaccord Genuity
Hold
Maintained
$374.00
+15.4%
08/04/2026
Larry Biegelsen
Wells Fargo
Hold
Maintained
$374.00
+15.4%
08/03/2026
Kendall Au
RBC Capital
Hold
Maintained
$374.00
+15.4%
07/31/2026
Shagun Singh Chadha
RBC Capital
Hold
Maintained
$374.00
+15.4%
07/31/2026
Ryan Zimmerman
BTIG
Hold
Maintained
-
-
07/10/2026
Joanne Wuensch
Citi
Hold
Maintained
$350.00
+8%
07/08/2026
Vijay Kumar
Evercore ISI
Buy
Maintained
$320.00
-1.3%
07/06/2026
Michael Matson
Needham
Hold
Maintained
-
-
02/25/2026
Last report
Jul 30, 2026
Fiscal period
Q2 2026
EPS / Est. (USD)
$1.01 / $1.18
-14.42%miss
Revenue / Est. (USD)
390.05M / 390.08M
-0.01%miss
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
354.68M
385.38M
374.76M
390.05M
Cost of goods sold
114.27M
123.26M
121.35M
125.10M
Cost of revenue
114.27M
123.26M
121.35M
125.10M
Research and development expenses
22.68M
21.79M
22.38M
25.40M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
168.90M
181.10M
192.80M
198.51M
Operating expense
191.58M
202.90M
215.18M
223.90M
Total operating expenses
305.85M
326.15M
336.52M
349.01M
Operating income
48.84M
59.23M
38.23M
41.04M
Other non operating income
-
593.00K
-
-
EBT including unusual items
52.32M
63.63M
41.69M
46.19M
EBT excluding unusual items
52.32M
63.63M
41.69M
46.19M
Income tax expense
6.47M
16.29M
9.10M
11.38M
Effective tax rate
12.37%
25.60%
21.84%
24.63%
Other operating expenses
-
-
-
-
Net income
45.85M
47.34M
32.58M
34.81M
Net profit margin
12.93%
12.28%
8.69%
8.92%
Earnings per share
0.97
1.18
1.01
1.01
Interest and investment income
4.36M
4.56M
4.87M
5.92M
Interest expense
-338.00K
-333.00K
-317.00K
-311.00K
Net interest expenses
4.02M
4.23M
4.55M
5.60M
Depreciation and amortization charges
-
-
-
-
EBITDA
51.33M
63.49M
42.81M
46.65M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps